CancerVax

CancerVAX is a pre-clinical biotech company developing a universal cancer vaccine.

According to the World Health Organization, cancer is the second-leading cause of death globally. And cancer vaccines are some of the latest weapons designed to fight this disease. By 2030, the cancer immunotherapy market is expected to reach $196 billion.

CancerVAX is developing a vaccine that will use the body’s own immune system to fight cancer. The company is headed by CEO Ryan Davies, who has co-founded multiple biotech companies. To aid in its development, CancerVAX is working with two research programs at the renowned cancer center at UCLA.

Team Background

Ryan Davies - Chief Executive Officer

Byron Elton - Chief Marketing Officer

Co-Investors